John B. Sanfilippo & Son (NASDAQ:JBSS – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Monday.
John B. Sanfilippo & Son Stock Down 2.5 %
Shares of NASDAQ:JBSS traded down $2.15 during trading on Monday, hitting $83.16. 80,593 shares of the company were exchanged, compared to its average volume of 63,480. The stock has a market cap of $964.66 million, a price-to-earnings ratio of 17.88 and a beta of 0.11. John B. Sanfilippo & Son has a fifty-two week low of $79.07 and a fifty-two week high of $108.96. The firm has a fifty day moving average price of $93.31 and a two-hundred day moving average price of $97.13. The company has a current ratio of 2.06, a quick ratio of 0.77 and a debt-to-equity ratio of 0.02.
John B. Sanfilippo & Son (NASDAQ:JBSS – Get Free Report) last issued its earnings results on Tuesday, August 20th. The company reported $0.86 EPS for the quarter. John B. Sanfilippo & Son had a return on equity of 17.21% and a net margin of 4.90%. The company had revenue of $269.57 million during the quarter.
Institutional Trading of John B. Sanfilippo & Son
John B. Sanfilippo & Son Company Profile
John B. Sanfilippo & Son, Inc, through its subsidiary, JBSS Ventures, LLC, processes and distributes tree nuts and peanuts in the United States. The company offers raw and processed nuts, including almonds, pecans, peanuts, black walnuts, English walnuts, cashews, macadamia nuts, pistachios, pine nuts, Brazil nuts, and filberts in various styles and seasonings.
See Also
- Five stocks we like better than John B. Sanfilippo & Son
- Most active stocks: Dollar volume vs share volume
- Intel: Is Now the Time to Be Brave?Â
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Dividend Capture Strategy: What You Need to Know
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for John B. Sanfilippo & Son Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John B. Sanfilippo & Son and related companies with MarketBeat.com's FREE daily email newsletter.